opl-ccl2-lpm
Recombinant proteinexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2009 (NCT00856674)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- C-C motif chemokine 2INHIBITOR
CCL2 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- opl-ccl2-lpm
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00856674 | Phase 1 | Mar 1, 2009 | Memorial University of Newfoundland, Osprey Pharmaceuticals USA, Inc., University of Montreal, University of Toronto |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Memorial University of Newfoundland | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Osprey Pharmaceuticals USA, Inc. | For profit | 1 | 1 | 1 | 2009 |
| University of Montreal | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Toronto | Academic/Hospital | 1 | 0 | 1 | 2009 |
4 organizations
Page 1 / 1